로딩 중…
StockDiggingStockDigging

제닉

123330· KOSDAQ
₩19,090-5.26%
2026-06-19

Price Chart

제닉-55.19%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap152.12B KRW
Revenue89.73B KRW
Net Income18.85B KRW
Total Assets66.90B KRW
Net Assets44.56B KRW
Employees356
Value
P/E8.07x
P/B3.41x
P/S1.70x
EV/EBITDA10.19x
FCF Yield11.82%
Profitability
ROE42.30%
ROA28.17%
Op. Margin16.30%
Revenue Growth64.66%
Earnings Growth-1.13%
Financial Health
Debt Ratio150.14%
Total Debt2.21B KRW
FCF17.98B KRW
Cash5.34B KRW
Current Ratio1.95x
Net Debt/EBITDA-0.21x
Performance
1Y Return-55.19%
1M Return-6.88%
From 52W High-56.71%
1Y MDD-62.63%
Trading
Volume79,923 shares
Foreign Own.1.63%
Per Share
EPS2,365 KRW
BPS5,694 KRW

Company Info

CEO 허남
Employees 356
Founded 2001
HQ 경기도 성남시, KR
Website genic21.com

Established in 2001 for the research, development, manufacturing, and sale of cosmetics and pharmaceuticals, the company was listed on KOSDAQ in 2011 and owns a wholly-owned sales corporation in China. Its core business revolves around R&D, manufacturing, and sales, leveraging its globally patented hydrogel technology. The company's brands are distributed through diverse channels, with online sales boosted by social media and influencer marketing. Increased product development and production requests reflect the acquisition of CGMP and various international certifications. Genic is headquartered in Seongnam-si, Gyeonggi-do.